NR2F6 and acute myeloid leukemia: The expression of NR2F6 is significantly up-regulated in a variety of malignant tumors, such as acute myeloid leukemia (AML) (15), breast cancer (16), Head and neck squamous cell carcinoma (17), colon cancer (18), and lymphoma (19).